Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Factors affecting willingness to provide buprenorphine treatment.

Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA; BHIVES Collaborative.

J Subst Abuse Treat. 2009 Apr;36(3):244-51. doi: 10.1016/j.jsat.2008.06.006. Epub 2008 Aug 20.

2.

Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists.

Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA.

Psychiatr Serv. 2008 Aug;59(8):909-16. doi: 10.1176/ps.2008.59.8.909.

PMID:
18678689
3.

Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.

DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA Jr.

Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4. Review.

4.

Geographic and specialty distribution of US physicians trained to treat opioid use disorder.

Rosenblatt RA, Andrilla CH, Catlin M, Larson EH.

Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.

5.
6.

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.

Walley AY, Alperen JK, Cheng DM, Botticelli M, Castro-Donlan C, Samet JH, Alford DP.

J Gen Intern Med. 2008 Sep;23(9):1393-8. doi: 10.1007/s11606-008-0686-x.

7.
8.

Nurse practitioner and physician assistant interest in prescribing buprenorphine.

Roose RJ, Kunins HV, Sohler NL, Elam RT, Cunningham CO.

J Subst Abuse Treat. 2008 Jun;34(4):456-9. Epub 2007 Jul 30.

9.

Training HIV physicians to prescribe buprenorphine for opioid dependence.

Sullivan LE, Tetrault J, Bangalore D, Fiellin DA.

Subst Abus. 2006 Sep;27(3):13-8.

PMID:
17135176
10.

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.

PMID:
15450648
11.

Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.

Li X, Shorter D, Kosten TR.

Expert Opin Pharmacother. 2014 Oct;15(15):2263-75. doi: 10.1517/14656566.2014.955469. Epub 2014 Aug 29. Review.

PMID:
25171726
12.

Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.

Arfken CL, Johanson CE, di Menza S, Schuster CR.

J Subst Abuse Treat. 2010 Sep;39(2):96-104. doi: 10.1016/j.jsat.2010.05.004. Epub 2010 Jul 3.

PMID:
20598829
13.

Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.

Bachireddy C, Weisberg DF, Altice FL.

Addiction. 2015 Dec;110(12):1869-71. doi: 10.1111/add.13055. Epub 2015 Oct 13. No abstract available.

PMID:
26464200
14.

Barriers to primary care physicians prescribing buprenorphine.

Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA.

Ann Fam Med. 2014 Mar-Apr;12(2):128-33. doi: 10.1370/afm.1595.

15.

Managing opioid addiction with buprenorphine.

Donaher PA, Welsh C.

Am Fam Physician. 2006 May 1;73(9):1573-8. Review.

16.

Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.

Edelman EJ, Dinh AT, Moore BA, Schottenfeld RS, Fiellin DA, Sullivan LE.

J Addict Med. 2012 Jun;6(2):159-65. doi: 10.1097/ADM.0b013e31824339fc.

17.
18.

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW.

Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137.

19.

Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians.

Cunningham CO, Kunins HV, Roose RJ, Elam RT, Sohler NL.

J Gen Intern Med. 2007 Sep;22(9):1325-9. Epub 2007 Jul 10.

20.

The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.

Stein BD, Gordon AJ, Sorbero M, Dick AW, Schuster J, Farmer C.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):72-8. doi: 10.1016/j.drugalcdep.2011.10.016. Epub 2011 Nov 16.

PMID:
22093488

Supplemental Content

Support Center